BIGG

A British Society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies

Scully, M; Rayment, R; Clark, A; Westwood, J. P; Cranfield, T; Gooding, R; Bagot, C. N; Taylor, A; Sankar, V; Gale, D; Dutt, T; McIntyre, J; Lester, W.

Br. j. haematol; 203 (4), 2023

The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these ar...

Thrombotic Microangiopathies/diagnosis, Purpura, Thrombotic Thrombocytopenic/diagnosis, Antibodies, Monoclonal/therapeutic use, Immunization, Passive, Blood-Derivative Drugs, Thrombotic Microangiopathies/therapy, Purpura, Thrombotic Thrombocytopenic/therapy

Fulltext

Therapeutics and COVID-19: living guideline - 16 September 2022

The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...